Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
Smith MR, Saad F, Chowdhury S, Oudard S, Hadaschik BA, Graff JN, Olmos D, Mainwaring PN, Lee JY, Uemura H, Lopez-Gitlitz A, Trudel GC, Espina BM, Shu Y, Park YC, Rackoff WR, Yu MK, Small EJ; SPARTAN Investigators.
N Engl J Med. 2018 Apr 12;378(15):1408-1418. doi: 10.1056/NEJMoa1715546. Epub 2018 Feb 8.
Tumor microenvironment in lung cancer-derived brain metastasis.
Liu W, Powell CA, Wang Q.
Chin Med J (Engl). 2022 Aug 5;135(15):1781-1791. doi: 10.1097/CM9.0000000000002127.
Abiraterone in metastatic prostate cancer without previous chemotherapy.
Ryan CJ, Smith MR, de Bono JS, Molina A, Logothetis CJ, de Souza P, Fizazi K, Mainwaring P, Piulats JM, Ng S, Carles J, Mulders PF, Basch E, Small EJ, Saad F, Schrijvers D, Van Poppel H, Mukherjee SD, Suttmann H, Gerritsen WR, Flaig TW, George DJ, Yu EY, Efstathiou E, Pantuck A, Winquist E, Higano CS, Taplin ME, Park Y, Kheoh T, Griffin T, Scher HI, Rathkopf DE; COU-AA-302 Investigators.
N Engl J Med. 2013 Jan 10;368(2):138-48. doi: 10.1056/NEJMoa1209096. Epub 2012 Dec 10.
Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts.
Bhattacharjee S, Hamberger F, Ravichandra A, Miller M, Nair A, Affo S, Filliol A, Chin L, Savage TM, Yin D, Wirsik NM, Mehal A, Arpaia N, Seki E, Mack M, Zhu D, Sims PA, Kalluri R, Stanger BZ, Olive KP, Schmidt T, Wells RG, Mederacke I, Schwabe RF.
J Clin Invest. 2021 Jun 1;131(11):e146987. doi: 10.1172/JCI146987.
Cinobufacini Inhibits Colon Cancer Invasion and Metastasis via Suppressing Wnt/beta-Catenin Signaling Pathway and EMT.
Wang J, Cai H, Liu Q, Xia Y, Xing L, Zuo Q, Zhang Y, Chen C, Xu K, Yin P, Chen T.
Am J Chin Med. 2020;48(3):703-718. doi: 10.1142/S0192415X20500354. Epub 2020 Apr 24.
Desmoplastic trichoepithelioma.
Brownstein MH, Shapiro L.
Cancer. 1977 Dec;40(6):2979-86. doi: 10.1002/1097-0142(197712)40:6<2979::aid-cncr2820400633>3.0.co;2-8.
Cancer metastasis: issues and challenges.
Qian CN, Mei Y, Zhang J.
Chin J Cancer. 2017 Apr 3;36(1):38. doi: 10.1186/s40880-017-0206-7.
Tumor Biomechanics Alters Metastatic Dissemination of Triple Negative Breast Cancer via Rewiring Fatty Acid Metabolism.
Filipe EC, Velayuthar S, Philp A, Nobis M, Latham SL, Parker AL, Murphy KJ, Wyllie K, Major GS, Contreras O, Mok ETY, Enriquez RF, McGowan S, Feher K, Quek LE, Hancock SE, Yam M, Tran E, Setargew YFI, Skhinas JN, Chitty JL, Phimmachanh M, Han JZR, Cadell AL, Papanicolaou M, Mahmodi H, Kiedik B, Junankar S, Ross SE, Lam N, Coulson R, Yang J, Zaratzian A, Da Silva AM, Tayao M, Chin IL, Cazet A, Kansara M, Segara D, Parker A, Hoy AJ, Harvey RP, Bogdanovic O, Timpson P, Croucher DR, Lim E, Swarbrick A, Holst J, Turner N, Choi YS, Kabakova IV, Philp A, Cox TR.
Adv Sci (Weinh). 2024 Jun;11(23):e2307963. doi: 10.1002/advs.202307963. Epub 2024 Apr 11.
Vasculogenic mimicry and tumor metastasis.
Zhang J, Qiao L, Liang N, Xie J, Luo H, Deng G, Zhang J.
J BUON. 2016 May-Jun;21(3):533-41.
Precision medicine in breast cancer.
Naito Y, Urasaki T.
Chin Clin Oncol. 2018 Jun;7(3):29. doi: 10.21037/cco.2018.06.04.
